4.6 Article

Utility of Keratins as Biomarkers for Human Oral Precancer and Cancer

期刊

LIFE-BASEL
卷 12, 期 3, 页码 -

出版社

MDPI
DOI: 10.3390/life12030343

关键词

keratins; oral cancer; oral precancer; biomarker

向作者/读者索取更多资源

Human oral cancer is a major malignancy in the Indian subcontinent and worldwide. Squamous cell carcinomas (SCC) are the most common type of oral cancer, with over 90% of cases being SCC. The survival rate for oral squamous cell carcinoma is relatively low, and late diagnosis, recurrence, and metastasis are the main causes of high mortality rates. Biomarkers, particularly keratins, may have value in predicting the development and progression of oral precancerous lesions and cancers. However, further research is needed in this area.
Human oral cancer is the single largest group of malignancies in the Indian subcontinent and the sixth largest group of malignancies worldwide. Squamous cell carcinomas (SCC) are the most common epithelial malignancy of the oral cavity, constituting over 90% of oral cancers. About 90% of OSCCs arise from pre-existing, potentially malignant lesions. According to WHO, OSCC has a 5-year survival rate of 45-60%. Late diagnosis, recurrence, and regional or lymph nodal metastases could be the main causes of the high mortality rates. Biomarkers may help categorize and predict premalignant lesions as high risk of developing malignancy, local recurrence, and lymph nodal metastasis. However, at present, there is a dearth of such markers, and this is an area of ongoing research. Keratins (K) or cytokeratins are a group of intermediate filament proteins that show paired and differentiation dependent expression. Our laboratory and others have shown consistent alterations in the expression patterns of keratins in both oral precancerous lesions and tumors. The correlation of these changes with clinicopathological parameters has also been demonstrated. Furthermore, the functional significance of aberrant keratins 8/18 expression in the malignant transformation and progression of oral tumors has also been documented. This article reviews the literature that emphasizes the value of keratins as biomarkers for the prognostication of human oral precancers and cancers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients

Crismita Dmello, Sharada Sawant, Hunain Alam, Prakash Gangadaran, Saie Mogre, Richa Tiwari, Zinia D'Souza, Manish Narkar, Rahul Thorat, Komal Patil, Devendra Chaukar, Shubhada Kane, Milind Vaidya

PLOS ONE (2017)

Article Biochemistry & Molecular Biology

The multiple roles of the unfolded protein response regulator IRE1α in cancer

Fiona Chalmers, Saie Mogre, Jeongin Son, Nicholas Blazanin, Adam B. Glick

MOLECULAR CARCINOGENESIS (2019)

Article Multidisciplinary Sciences

Elevated levels of mitochondrial CoQ10 induce ROS-mediated apoptosis in pancreatic cancer

Tulin Dadali, Anne R. Diers, Shiva Kazerounian, Senthil K. Muthuswamy, Pallavi Awate, Ryan Ng, Saie Mogre, Carrie Spencer, Katerina Krumova, Hannah E. Rockwell, Justice McDaniel, Emily Y. Chen, Fei Gao, Karl T. Diedrich, Vijetha Vemulapalli, Leonardo O. Rodrigues, Viatcheslav R. Akmaev, Khampaseuth Thapa, Manuel Hidalgo, Arindam Bose, Vivek K. Vishnudas, A. James Moser, Elder Granger, Michael A. Kiebish, Stephane Gesta, Niven R. Narain, Rangaprasad Sarangarajan

Summary: Reactive oxygen species (ROS) play a role in triggering cell signaling events to promote and maintain tumorigenicity. Chemotherapy and radiation can induce ROS to elicit cell death, making it possible to target ROS pathways for effective anti-cancer therapeutics. Coenzyme Q(10) is shown to increase ROS generation when delivered to increase mitochondrial Q-pool, resulting in anti-cancer effects in a pancreatic cancer model.

SCIENTIFIC REPORTS (2021)

Article Biology

Biomarker Potential of Vimentin in Oral Cancers

Saie Mogre, Vidhi Makani, Swapnita Pradhan, Pallavi Devre, Shyam More, Milind Vaidya, Crismita Dmello

Summary: Oral carcinogenesis is a multistep process, with a substantial proportion of oral tumors developing from potentially malignant disorders. Current clinical and histological methods have limited ability to predict malignancy progression, highlighting the need for developing new biological markers. Vimentin, as demonstrated by extensive research, plays a significant role in oral cancer progression and can serve as a prognostic biomarker.

LIFE-BASEL (2022)

Article Oncology

Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma

Crismita Dmello, Aaron Sonabend, Victor A. Arrieta, Daniel Y. Zhang, Deepak Kanojia, Li Chen, Andrew Gould, Jiangshan Zhang, Seong Jae Kang, Jan Winter, Craig Horbinski, Christina Amidei, Balazs Gyorffy, Alex Cordero, Catalina Lee Chang, Brandyn Castro, Patrick Hsu, Atique U. Ahmed, Maciej S. Lesniak, Roger Stupp, Adam M. Sonabend

Summary: By analyzing genome-wide CRISPR knockout screen results and patient data, researchers identified endoplasmic reticulum protein SSR3 as a potential predictive biomarker for susceptibility to Paclitaxel in breast cancer and glioblastoma.

CLINICAL CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

TGFβ1 regulates HRas-mediated activation of IRE1α through the PERK-RPAP2 axis in keratinocytes

Saie Mogre, Nicholas Blazanin, Hailey Walsh, Jack Ibinson, Chase Minnich, Chih-Chi Andrew Hu, Adam B. Glick

Summary: The study found that TGF beta 1 plays a critical role in regulating tumor progression and can induce ER stress. The results showed that TGF beta 1 suppresses the phosphorylation and activation of IRE1 alpha through activating the PERK pathway, thereby exerting tumor-suppressive effects. In addition, TGF beta 1 also partially depends on the PERK-induced IRE1 alpha dephosphorylation and inactivation through PERK-dependent IRE1 alpha phosphatase.

MOLECULAR CARCINOGENESIS (2022)

Article Developmental Biology

The unfolded protein response gene Ire1α is required for tissue renewal and normal differentiation in the mouse tongue and esophagus

Fiona E. Chalmers, Saie Mogre, Bipin Rimal, Jeongin Son, Andrew D. Patterson, Douglas B. Stairs, Adam B. Glick

Summary: The IRE1 alpha-XBP1s signaling pathway is crucial for the proliferation and maturation of basal keratinocytes in the mouse tongue and esophageal epithelium, with its absence resulting in mucosal thinning and feeding impairment.

DEVELOPMENTAL BIOLOGY (2022)

Review Oncology

Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment

Edgar Petrosyan, Jawad Fares, Luis G. Fernandez, Ragini Yeeravalli, Crismita Dmello, Joseph T. Duffy, Peng Zhang, Catalina Lee-Chang, Jason Miska, Atique U. Ahmed, Adam M. Sonabend, Irina Balyasnikova, Amy B. Heimberger, Maciej S. Lesniak

Summary: Immunotherapy has had success in halting cancer progression, but it has not been effective for primary brain malignancies, which remain a globally lethal disease. Understanding how tumor cells survive and propagate within the unique microenvironment of the central nervous system (CNS) is crucial. Cancer genetic aberrations and metabolic abnormalities lead to persistent endoplasmic reticulum (ER) stress, which promotes tumor growth, invasion, therapeutic resistance, and reprogramming of immune cells. Targeting ER stress is a potential therapeutic approach for primary CNS tumors.

MOLECULAR CANCER RESEARCH (2023)

Article Multidisciplinary Sciences

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

Crismita Dmello, Junfei Zhao, Li Chen, Andrew Gould, Brandyn Castro, Victor A. Arrieta, Daniel Y. Zhang, Kwang-Soo Kim, Deepak Kanojia, Peng Zhang, Jason Miska, Ragini Yeeravalli, Karl Habashy, Ruth Saganty, Seong Jae Kang, Jawad Fares, Connor Liu, Gavin Dunn, Elizabeth Bartom, Matthew J. Schipma, Patrick D. Hsu, Mahmoud S. Alghamri, Maciej S. Lesniak, Amy B. Heimberger, Raul Rabadan, Catalina Lee-Chang, Adam M. Sonabend

Summary: This study identifies Chek2 as the most important kinase that promotes evasion of glioma cells from immune recognition. Genetic depletion or pharmacological inhibition of Chek2 enhances antigen presentation, STING pathway activation, and PD-L1 expression, leading to survival benefits in preclinical glioma models. Analysis of human GBMs shows a negative correlation between Chek2 expression and antigen presentation/T-cell activation. These results suggest that Chek2 may be a promising target for improving response to immune checkpoint blockade therapy.

NATURE COMMUNICATIONS (2023)

Article Medicine, Research & Experimental

Immune checkpoint blockade in glioblastoma from tumor heterogeneity to personalized treatment

Victor A. Arrieta, Crismita Dmello, Daniel J. McGrail, Daniel J. Brat, Catalina Lee-Chang, Amy B. Heimberger, Dhan Chand, Roger Stupp, Adam M. Sonabend

Summary: Immune checkpoint blockade (ICB) has revolutionized modern cancer therapy, arousing great interest in the neuro-oncology community. While several reports show that subsets of patients with glioma exhibit durable responses to immunotherapy, the efficacy of this treatment has not been observed for unselected patient populations, preventing its broad clinical implementation for gliomas and glioblastoma (GBM).

JOURNAL OF CLINICAL INVESTIGATION (2023)

暂无数据